Pfizer Research Rides the Wave

Pfizer's Research University (ePRU) has commissioned fast-growing BrightWave,to develop an e-learning module for Pfizer's re-designed education programme on the development of medicines

The BrightWave programme will form part of a modularized approach to education that will enable research teams, comprising pharmaceutical scientists, project managers, regulatory advisers and others, to participate more effectively in Exploratory Development, a key phase that can last up to three years.

Sue Ward, Pfizer Research University's senior adviser says that PRU is delighted to be using BrightWave's experience and approach to e-Learning development. "This is an ambitious new learning architecture for us which we are convinced will produce substantial rewards. BrightWave has the expertise and experience we need in an e-Learning partner and I'm excited that we are working together."

Pfizer Inc discovers, develops, manufactures and markets leading prescription medicines for humans and animals and many of the world's best-known consumer brands. In the UK, since 1990, Pfizer has invested over £1billion. The company employs more than 6000 people in the UK and is one of the top three suppliers of medicines to the NHS.

Founded by ex-PricewaterhouseCoopers consultants, Charles Gould and Simon Brown, BrightWave uses its production methodology to develop customised e-Learning content for a wide range of clients. Clients include private sector companies like PwC, ScottishPower, T-Mobile (formerly One 2 One), and Pfizer, government agencies such as the MoD and voluntary organisations like Age Concern.

June 14th, 2002